Transforming biomedical innovations into therapies
To make a meaningful difference in patients’ lives
more about us
-
UCB to acquire Candid Therapeutics, building upon its existing immunology pipeline with novel T-cell engagers
read more -
Two River and Vida Ventures Extend Track Record of Company Creation and Value Realization Following the Candid Therapeutics’ Acquisition by UCB
read more -
Avalyn Announces Closing of Initial Public Offering and Full Exercise of Underwriters’ Option to Purchase Additional Shares
read more
Core Values
patients
Keep front and center in all that we do
integrity
Hold ourselves and our partners to the highest standards
integrity
Hold ourselves and our partners to the highest standards
entrepreneurship
Take initiative to turn ideas into reality
entrepreneurship
Take initiative to turn ideas into reality
boldness
Drive breakthrough science into medicines
boldness
Drive breakthrough science into medicines
humility
Recognize that the best can come from anywhere
humility
Recognize that the best can come from anywhere
collaboration
Partner to create something grander than the parts
collaboration
Partner to create something grander than the parts
flexibility
Embrace each endeavor with an open mind
flexibility
Embrace each endeavor with an open mind
